Late and long-lasting response in an adult chronic idiopathic thrombocytopenic purpura after extended course of rituximab.
D'Arena
Giovanni
G
Luigiavigliotti
Maria
M
Coccaro
Mariarosa
M
Iodice
Giovanni
G
Tartarone
Alfredo
A
Matera
Rosella
R
Di Renzo
Nicola
N
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D001402:B-Lymphocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D012074:Remission Induction; D000069283:Rituximab; D013156:Splenectomy
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab; D011241:Prednisone